![Overactive bladder / Urodynamic testing / Urinary incontinence / Urinary retention / Astellas Pharma / Urinary bladder / National Association For Continence / Frequent urination / Percutaneous tibial nerve stimulation / Medicine / Urology / Incontinence Overactive bladder / Urodynamic testing / Urinary incontinence / Urinary retention / Astellas Pharma / Urinary bladder / National Association For Continence / Frequent urination / Percutaneous tibial nerve stimulation / Medicine / Urology / Incontinence](https://www.pdfsearch.io/img/2f41cefbf94dcef13ca51ff91a4a79db.jpg) Date: 2012-10-22 19:12:22Overactive bladder Urodynamic testing Urinary incontinence Urinary retention Astellas Pharma Urinary bladder National Association For Continence Frequent urination Percutaneous tibial nerve stimulation Medicine Urology Incontinence | | MYRBETRIQ™ (mirabegron), Overactive Bladder Treatment from Astellas, Now Available Through U.S. Pharmacies NORTHBROOK, Ill., Oct. 22, 2012 – Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyobased Add to Reading ListSource URL: www.astellas.comDownload Document from Source Website File Size: 59,17 KBShare Document on Facebook
|